Navigation Links
US Army Study Shows STB Lifesaving Technology's® FAST® Dressing Superior to the Most Effective Currently Available Agents for Controlling Arterial Bleeding
Date:1/27/2011

ROCKVILLE, Md., Jan. 27, 2011 /PRNewswire/ -- In a study conducted jointly by the US Army Institute of Surgical Research and STB Lifesaving Technologies®, and just published in The Journal of Trauma, STB®'s FAST® (Fibrin Adhesive STat) Dressing was shown to be superior to the most effective available agents for controlling severe arterial bleeding.

The study compared currently available agents with the FAST® dressing, in a coagulopathic hemorrhage model simulating a gunshot wound to a major peripheral artery.  The FAST® dressing produced significantly better outcomes (higher survival rate, longer survival time, higher incidence of stable hemostasis and less blood loss).  STB®'s FAST® dressing was the only agent that stopped bleeding and prevented exsanguination in most subjects.

"The consistently better results obtained using the FAST® Dressing reflect the results of applying the unique FAST® technology to this most challenging bleeding problem. The ability to optimally mix the fibrinogen and thrombin components during manufacture results in a hemostatic product of unprecedented effectiveness, flexibility and ease of handling. This technology is unaffected by the coagulation state of the patient and therefore functions when other types of products cannot. This has significant implications for the treatment of both military and civilian casualties," commented Dr. Martin MacPhee, STB®'s Chief Scientific Officer.

The report emphasizes the urgent need for methods such as this to control hemorrhage in the field and operating rooms to potentially reduce war mortality, as uncontrolled bleeding remains the leading cause of potentially preventable death in combat casualties.  Hemorrhage is also a leading cause of death in civilian trauma patients.

"Study after study has confirmed the faith we have in our product's ability to save lives, and it's why we refer to our technology as 'A Breakthrough for Life.' Test results such as this recent report demonstrate why the Army continues to support for our research, assisting us in accelerating the step-up to cGMP manufacturing, and the necessary work required to file for FDA approval to initiate human clinical trials," said Richard Moscarello, STB®'s CEO.  

About STB®  

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland. STB® is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural, patented FAST® technology platform, STB®'s products will be indispensable to both the military and civilian medical markets.


'/>"/>
SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
2. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
3. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
4. R-Tech Ueno Completes Phase 2a Clinical Study of RK-023 to Treat Androgenetic Alopecia
5. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
6. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
7. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
8. New Study on HIV/AIDS Redefines the Size, Scale, and Scope of Epidemic
9. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
10. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
11. Long Term Care Pharmacy Alliance Concerned with Proposed CMS Rule; New Study Confirms LTCPA Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Jan 20, 2017 Research and Markets ... Market Trends, Opportunities, and Future" report to their offering. ... This research service ... trends, and technologies, and provides a snapshot of the key participants ... and forecasts are provided from 2016 to 2020. The market is ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery Devices ... the Germany Cataract Surgery Devices market. The report provides ... and average prices (USD) within market segements - Phacoemulsification ... also provides company shares and distribution shares data for ...
(Date:1/19/2017)... Call and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) ... for the fourth quarter of 2016 on Wednesday, February 15, 2017, ... ... ET on Wednesday, February 15, 2017, during which management will discuss ... corporate activities. To participate in the conference call, please dial 1-888-771-4371 ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... ... “The Inn at the Mill”: a story of love and redemption, hope and uncertainty ... and content. , “The Inn at the Mill” is the creation of published author, ... and is now living in Berks County on Crow Hill. The inn, the ...
(Date:1/23/2017)... ... ... a time when many people celebrate romance and love by giving cards, candy, flowers or ... present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day special: Spend $100 ... $50 free. , “A lot of people just buy the more predictable gift of ...
(Date:1/21/2017)... FL (PRWEB) , ... January 21, 2017 , ... Caronlab ... recently attended the January ECRM Trade Show in Hilton Head, SC, where it benefited ... reputation for the quality of its beauty and wellness products. At this trade show, ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/20/2017)... MT (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable ... saving deck space. Since the lift is mounted on wheels, it can be wheeled out ... lock down kit, to fasten to the deck. "We have transformed the feedback from customers ...
Breaking Medicine News(10 mins):